Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PHC HoldingsPHCCF 55 EV-to-EBIT is 13.12 as of Jul. 27, 2026, which is 24% below its 10-year median of 17.21. GuruFocus rates PHCCF with a GF Score™ of 55/100 and a GF Value™ of $7.54. The stock has 11 warning signs investors should review. Among 466 Medical Devices & Instruments companies, PHC Holdings ranks better than 63.3% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PHC Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was $2,129 Mil.
PHC Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $151 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHC Holdings EV-to-EBIT Related Terms
PHC Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for PHC Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PHC Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PHC Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PHC Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PHC Holdings's EV-to-EBIT falls into.
PHC Holdings's current Enterprise Value is $1,987 Mil.
PHC Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $151 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHC Holdings (PHCCF) has a EV-to-EBIT of 13.12 as of Jul. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PHC Holdings and its competitors. This is 24% below median its historical median of 17.21. According to the industry distribution chart, PHC Holdings ranks #171 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 36.7%.
Is PHC Holdings' EV-to-EBIT too high?
PHC Holdings' current EV-to-EBIT of 13.12 is 24% below median its 10-year median of 17.21. The Medical Devices & Instruments industry median EV-to-EBIT is 18.40. PHC Holdings' value of 13.12 is 28.7% below this industry median. Based on the distribution chart, PHC Holdings ranks #171 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, PHC Holdings has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does PHC Holdings' EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PHC Holdings ranks #171 out of 466 companies for EV-to-EBIT. This puts PHC Holdings in the upper half of its industry. The industry median EV-to-EBIT is 18.40. PHC Holdings' value of 13.12 is 28.7% below this benchmark. While the company's 10-year median is 17.21 vs. the industry median of 18.40, PHC Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.40, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PHC Holdings's current EV-to-EBIT of 13.12 is 28.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PHC Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PHC Holdings's current EV-to-EBIT is 13.12, which is 24% below median its own 10-year median of 17.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PHC Holdings stock overvalued right now?
PHC Holdings (PHCCF) has a current EV-to-EBIT of 13.12. The stock's GF Value™ is $7.54, compared to a current price of $7.41 — trading 1.7% below its estimated fair value. The current EV-to-EBIT is 13.12, which is 24% below median its 10-year median of 17.21 and 28.7% below the Medical Devices & Instruments industry median of 18.40. PHC Holdings' overall GF Score™ is 55/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For PHC Holdings (PHCCF), the current EV-to-EBIT is 13.12 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PHC Holdings (PHCCF) Overvalued in 2026?
Based on GuruFocus' analysis, PHC Holdings stock appears to be undervalued.
The current stock price of $7.41 is trading 1.7% below its estimated GF Value™ of $7.54.
Key valuation signals for PHCCF:
EV-to-EBIT: 13.12 (24% below median its 10-year median of 17.21)
GF Value™: $7.54 vs. price of $7.41 (1.7% below fair value)
Industry Position: 28.7% below the Medical Devices & Instruments median (#171 of 466)
No single metric tells the full story. See the PHCCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHCCF has been successfully added to your 
